Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Cleveland, OH
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Hershey, PA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Nashville, TN
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
San Antonio, TX
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Seattle, WA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
mi
from
Adelaide,
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
mi
from
Adelaide,
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
Status: Enrolling
Updated:  7/25/2016
Clinical Research Laboratories, LLC
mi
from
Piscataway, NJ
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
Status: Enrolling
Updated: 7/25/2016
Clinical Research Laboratories, LLC
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan™-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Status: Enrolling
Updated:  8/1/2016
Cleveland Clinic
mi
from
Cleveland, OH
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan™-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Status: Enrolling
Updated: 8/1/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Encino, CA
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Granada Hills, CA
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Granada Hills, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Mission Viejo, CA
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Louisville, KY
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Ypsilanti, MI
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Portland, OR
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Warwick, RI
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Webster, TX
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  8/1/2016
Research Site
mi
from
Surrey,
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 8/1/2016
Research Site
mi
from
Surrey,
Click here to add this to my saved trials
Tofacitnib for the Treatment of Alopecia Areata and Variants
Tofacitnib for the Treatment of Alopecia Areata and Variants
Status: Enrolling
Updated:  8/8/2016
Yale University
mi
from
New Haven, CT
Tofacitnib for the Treatment of Alopecia Areata and Variants
Tofacitnib for the Treatment of Alopecia Areata and Variants
Status: Enrolling
Updated: 8/8/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
Status: Enrolling
Updated:  8/10/2016
Yale University
mi
from
New Haven, CT
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
Status: Enrolling
Updated: 8/10/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Investigation Site #1
mi
from
Hot Springs, AR
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Investigation Site #1
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Fremont, CA
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Fremont, CA
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Sacramento, CA
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Tampa, FL
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Marietta, GA
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Arlington Hts, IL
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Arlington Hts, IL
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Crowley, LA
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Crowley, LA
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Fridley, MN
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Johnston, RI
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Johnston, RI
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
Austin, TX
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated:  8/15/2016
Clinical Research Facility
mi
from
College Station, TX
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Status: Enrolling
Updated: 8/15/2016
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  10/27/2016
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 10/27/2016
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
Randomized Controlled Trial of an Eczema Care Plan
Randomized Controlled Trial of an Eczema Care Plan
Status: Enrolling
Updated:  11/30/2016
Boston Children's Hospital
mi
from
Boston, MA
Randomized Controlled Trial of an Eczema Care Plan
Randomized Controlled Trial of an Eczema Care Plan
Status: Enrolling
Updated: 11/30/2016
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Contact Sensitization Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated:  11/30/2016
HillTop Research Corporation
mi
from
Scottsdale, AZ
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Contact Sensitization Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated: 11/30/2016
HillTop Research Corporation
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Photoallergic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated:  11/30/2016
HillTop Research Corporation
mi
from
St. Petersburg, FL
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Photoallergic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Status: Enrolling
Updated: 11/30/2016
HillTop Research Corporation
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Fremont, CA
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Fremont, CA
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Louisville, KY
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Rockville, MD
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Belleville, NJ
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Belleville, NJ
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Montclair, NJ
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Montclair, NJ
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Stony Brook, NY
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Stony Brook, NY
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
High Point, NC
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials